Report cover image

Trillium Therapeutics Inc - Strategic SWOT Analysis Review

Publisher GlobalData
Published Jul 22, 2022
Length 29 Pages
SKU # GBDT17329609

Description

Trillium Therapeutics Inc - Strategic SWOT Analysis Review

- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

Trillium Therapeutics Inc (Trillium), formerly Neurogenesis Biotech Corp, a subsidiary of Pfizer Inc, is a clinical-stage immuno-oncology company, which develops novel therapies for the treatment of cancer. The company uses biologic and small molecule-based approaches to develop its portfolio. Its lead program, TTI-621 (intravenous), a SIRPaFc fusion protein is evaluated for the treatment of B and T-cell lymphomas and also for other blood cancers. Trillium is also developing TTI-621 (intratumoral) for solid cancers and T- cell lymphomas; TTI-622 for lymphoma and myeloma; and small molecule STING agonist TTI -10001 for cancers. Trillium is headquartered in Cambridge, Massachusetts, the US.

Trillium Therapeutics Inc Key Recent Developments

Nov 18,2021: Pfizer acquires immuno-oncology firm Trillium for $2.22bn
Aug 24,2021: Pfizer agrees to acquire Trillium Therapeutics for $2.26bn
Aug 13,2021: Trillium Therapeutics Reports Second Quarter 2021 Operating and Financial Results
Jun 30,2021: Trillium Therapeutics Appoints Catherine Mackey, Ph.D., to Its Board of Directors
Jun 09,2021: Trillium Announces Voting Results From the Annual General and Special Meeting of Shareholders

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

29 Pages
Section 1 - About the Company
Trillium Therapeutics Inc - Key Facts
Trillium Therapeutics Inc - Key Employees
Trillium Therapeutics Inc - Key Employee Biographies
Trillium Therapeutics Inc - Major Products and Services
Trillium Therapeutics Inc - History
Trillium Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Trillium Therapeutics Inc - Business Description
Trillium Therapeutics Inc - Corporate Strategy
Trillium Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Trillium Therapeutics Inc - Strengths
Trillium Therapeutics Inc - Weaknesses
Trillium Therapeutics Inc - Opportunities
Trillium Therapeutics Inc - Threats
Trillium Therapeutics Inc - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
Trillium Therapeutics Inc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Aug 13, 2021: Trillium Therapeutics Reports Second Quarter 2021 Operating and Financial Results
Jun 30, 2021: Trillium Therapeutics Appoints Catherine Mackey, Ph.D., to Its Board of Directors
Jun 09, 2021: Trillium Announces Voting Results From the Annual General and Special Meeting of Shareholders
May 07, 2021: Trillium Therapeutics Reports First Quarter 2021 Operating and Financial Results
Apr 22, 2021: Trillium Therapeutics to host virtual R&D day for investors on April 28, 2021
Mar 18, 2021: Trillium Therapeutics Reports Annual Operating and Financial Results and Sets Date for R&D Day
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Trillium Therapeutics Inc, Key Facts
Trillium Therapeutics Inc, Key Employees
Trillium Therapeutics Inc, Key Employee Biographies
Trillium Therapeutics Inc, Major Products and Services
Trillium Therapeutics Inc, History
Trillium Therapeutics Inc, Other Locations
Trillium Therapeutics Inc, Subsidiaries
Trillium Therapeutics Inc, Key Competitors
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
Trillium Therapeutics Inc, Recent Deals Summary
List of Figures
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2016 to YTD 2022

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us